Insitro vs Biconomy

Side-by-side comparison of AI visibility scores, market position, and capabilities

Insitro leads in AI visibility (27 vs 20)
Insitro logo

Insitro

EmergingBiotechnology

ML Drug Discovery

Drug discovery company founded by Daphne Koller integrating ML with high-throughput biology; raised $400M+ to build proprietary biological datasets for predicting drug targets and clinical outcomes in neurology, metabolic, and oncology programs.

AI VisibilityBeta
Overall Score
D27
Category Rank
#1 of 1
AI Consensus
72%
Trend
up
Per Platform
ChatGPT
38
Perplexity
26
Gemini
29

About

Insitro is a drug discovery company founded in 2018 by Daphne Koller, a pioneer in machine learning and computational biology, having raised over $400M to build an integrated ML and biology platform. The company generates large-scale biological datasets using automated laboratory systems and human induced pluripotent stem cell models of disease, then trains machine learning models on this data to predict drug targets, patient stratification, and clinical outcomes. Unlike companies that apply ML to existing datasets, Insitro builds proprietary biological datasets specifically designed to train predictive models for drug discovery. The platform is being applied to neurological diseases, metabolic disorders, and oncology with the goal of identifying drug candidates more likely to succeed in clinical trials. Insitro has established partnerships with major pharmaceutical companies including Gilead Sciences and Bristol Myers Squibb to co-develop drugs using the platform. The company represents a model for how ML can be deeply integrated into pharmaceutical R&D rather than applied as a surface-level analytical layer.

Full profile
Biconomy logo

Biconomy

EmergingWeb3

Web3 Transaction Infrastructure

Web3 authentication and account abstraction infrastructure enabling gasless transactions and simplified dApp onboarding; ERC-4337 implementation allows dApps to sponsor gas fees on behalf of users and accept ERC-20 token gas payment for mainstream-accessible wallet experiences.

AI VisibilityBeta
Overall Score
D20
Category Rank
#1 of 1
AI Consensus
55%
Trend
up
Per Platform
ChatGPT
13
Perplexity
26
Gemini
13

About

Biconomy is a Web3 infrastructure platform focused on making decentralized applications usable by mainstream audiences who are not familiar with cryptocurrency gas mechanics. Its core product implements account abstraction via ERC-4337, allowing dApp developers to sponsor gas fees on behalf of users, accept gas payment in ERC-20 tokens instead of native currency, and batch multiple on-chain transactions into a single user action. These capabilities transform the user experience from one requiring native token balances and technical awareness into something closer to a conventional web application workflow.

Full profile

AI Visibility Head-to-Head

27
Overall Score
20
#1
Category Rank
#1
72
AI Consensus
55
up
Trend
up
38
ChatGPT
13
26
Perplexity
26
29
Gemini
13
31
Claude
28
34
Grok
15

Key Details

Category
ML Drug Discovery
Web3 Transaction Infrastructure
Tier
Emerging
Emerging
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Insitro
ML Drug Discovery
Only Biconomy
Web3 Transaction Infrastructure

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.